On Behalf of the SFGM-TC: Retrospective Comparison of Reduced and Higher Intensity Conditioning for High-Risk Myelodysplastic Syndrome Treated With Allogeneic Stem-Cell Transplantation.
Campidelli, A., et al. (2021) Clinical Lymphoma, Myeloma & Leukemia [record in progress]
Treatment of Allosensitized Patients Receiving Allogeneic Transplantation.
Ciurea, S., et al (2021) Blood Advances [record in progress]
Autologous and Allogeneic Hematopoietic Cell Transplantation for Diffuse Large B-cell Lymphoma-Type Richter Syndrome.
Herrera, A.F. et al. (2021) Blood Advances [record in progress]
The Effect of Duration of Lenalidomide Maintenance and Outcomes of Different Salvage Regimens in Patients with Multiple Myeloma (MM).
Ho, M., et al. (2021) Blood Cancer Journal 11(9):158
Impact of conditioning intensity and regimen on transplant outcomes in patients with adult T-cell leukemia-lymphoma.
Innoue, Y., (2021) Bone Marrow Transplantation [record in progress]
Impact of allogeneic stem cell transplantation comorbidity indexes after haplotransplant using post-transplant cyclophosphamide.
Jullien, M., et al. (2021) Cancer Medicine [record in progress]
Bone Marrow versus Peripheral Blood Graft for Haploidentical HCT with Post Transplantation Cyclophosphamide.
Mehta, R. S., (2021) Transplantation and Cellular Therapy [record in progress]
Planned granulocyte-colony stimulating factor adversely impacts survival after allogeneic hematopoietic cell transplantation performed with Thymoglobulin for myeloid malignancy.
Orfali, N., et al. (2021) Transplantation and Cellular Therapy [record in progress]
Impact of mother donor, peripheral blood stem cells and measurable residual disease on outcomes after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide in children with acute leukaemia.
Rocha, V., et al. (2021) Bone Marrow Transplantation [record in progress]
+++++
No comments:
Post a Comment